149 related articles for article (PubMed ID: 26700672)
1. Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms.
Kasajova P; Holubekova V; Mendelova A; Lasabova Z; Zubor P; Kudela E; Biskupska-Bodova K; Danko J
Tumour Biol; 2016 Jun; 37(6):7929-37. PubMed ID: 26700672
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype.
Delfino RJ; Smith C; West JG; Lin HJ; White E; Liao SY; Gim JS; Ma HL; Butler J; Anton-Culver H
Pharmacogenetics; 2000 Jul; 10(5):461-9. PubMed ID: 10898115
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.
Hunter DJ; Hankinson SE; Hough H; Gertig DM; Garcia-Closas M; Spiegelman D; Manson JE; Colditz GA; Willett WC; Speizer FE; Kelsey K
Carcinogenesis; 1997 Nov; 18(11):2127-32. PubMed ID: 9395212
[TBL] [Abstract][Full Text] [Related]
6. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
[TBL] [Abstract][Full Text] [Related]
7. N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium.
Cox DG; Dostal L; Hunter DJ; Le Marchand L; Hoover R; Ziegler RG; Thun MJ;
Am J Epidemiol; 2011 Dec; 174(11):1316-22. PubMed ID: 22074863
[TBL] [Abstract][Full Text] [Related]
8. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.
Ambrosone CB; Freudenheim JL; Graham S; Marshall JR; Vena JE; Brasure JR; Michalek AM; Laughlin R; Nemoto T; Gillenwater KA; Shields PG
JAMA; 1996 Nov; 276(18):1494-501. PubMed ID: 8903261
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between passive smoking, breast cancer risk and n-acetyltransferase 2 (NAT2)].
Avraham Z; Baron-Epel O; Boker LK
Harefuah; 2014; 153(3-4):171-5, 238. PubMed ID: 24791559
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.
Baumgartner KB; Schlierf TJ; Yang D; Doll MA; Hein DW
Toxicol Sci; 2009 Nov; 112(1):211-20. PubMed ID: 19692670
[TBL] [Abstract][Full Text] [Related]
12. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
[TBL] [Abstract][Full Text] [Related]
14. Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study.
Regev-Avraham Z; Baron-Epel O; Hammond SK; Keinan-Boker L
Breast Cancer; 2018 Mar; 25(2):176-184. PubMed ID: 29071579
[TBL] [Abstract][Full Text] [Related]
15. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
16. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer.
Slattery ML; Edwards S; Curtin K; Schaffer D; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):882-9. PubMed ID: 14504199
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
18. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
[TBL] [Abstract][Full Text] [Related]
20. Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population.
Gogolewska M; Kabziński J; Majsterek I
Int J Occup Med Environ Health; 2023 Dec; 36(6):812-824. PubMed ID: 38099560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
